Structured evidence table for Probiotic Blood Lipids Randomized Trial, generated from 2 reusable source documents in the Migaku knowledge base.
| topic | claim | evidence level | citation | source |
|---|---|---|---|---|
| Probiotic Blood Lipids Randomized Trial | Background Cardiovascular diseases, driven significantly by dyslipidemia, remain a leading global mortality risk. | 1 | Zuo J (2025) | Effect of Probiotics Containing <i>Lactobacillus plantarum</i> on Blood Lipids: Systematic Review, Meta-Analysis, and Network Pharmacological Analysis. |
| Probiotic Blood Lipids Randomized Trial | plantarum supplementation significantly reduced TC (SMD: -0.233; 95% CI: -0.458, -0.008; p = 0.042), TG (SMD: -0.227; 95% CI: -0.432, -0.021; p = 0.030), and LDL-C (SMD: -0.251; 95% CI: -0.477, -0.025; p = 0.029), but not HDL-C. | 1 | Zuo J (2025) | Effect of Probiotics Containing <i>Lactobacillus plantarum</i> on Blood Lipids: Systematic Review, Meta-Analysis, and Network Pharmacological Analysis. |
| Probiotic Blood Lipids Randomized Trial | plantarum ), which is a probiotic commonly used in a variety of food products, may contribute to the regulation of blood lipids, although prior studies report inconsistent efficacy and lack mechanistic clarity. | 1 | Zuo J (2025) | Effect of Probiotics Containing <i>Lactobacillus plantarum</i> on Blood Lipids: Systematic Review, Meta-Analysis, and Network Pharmacological Analysis. |
| Probiotic Blood Lipids Randomized Trial | Background Emerging evidence suggests gut microbiota modulation may influence neurocognitive function through the gut-brain axis. | 2 | Huang J (2025) | Probiotic supplementation on cognitive and other aging-related physiological functions in middle-aged and older adults with mild cognitive impairment (PCAMCI): protocol for a randomized, triple-blinded, placebo-controlled trial. |
| Probiotic Blood Lipids Randomized Trial | The findings may inform the development of strategies to delay cognitive decline by modulating the gut-brain axis in this high-risk population. | 2 | Huang J (2025) | Probiotic supplementation on cognitive and other aging-related physiological functions in middle-aged and older adults with mild cognitive impairment (PCAMCI): protocol for a randomized, triple-blinded, placebo-controlled trial. |
| Probiotic Blood Lipids Randomized Trial | Although preliminary studies indicate probiotics' potential benefits for mild cognitive impairment (MCI), well-designed randomized controlled trials remain limited. | 2 | Huang J (2025) | Probiotic supplementation on cognitive and other aging-related physiological functions in middle-aged and older adults with mild cognitive impairment (PCAMCI): protocol for a randomized, triple-blinded, placebo-controlled trial. |
Source documents